Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Abbott Laboratories, NextEra Energy, Silgan Holdings, UniFirst Corp and Landstar System

Read MoreHide Full Article

For Immediate Release

Chicago, IL – October 16, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Abbott Laboratories (ABT - Free Report) , NextEra Energy, Inc. (NEE - Free Report) , Silgan Holdings Inc. (SLGN - Free Report) , UniFirst Corporation (UNF - Free Report) and Landstar System, Inc. (LSTR - Free Report) .

Here are highlights from Thursday’s Analyst Blog:

Investment Strategy for Q3 Earnings in a Volatile Market

This week the third-quarter 2020 earnings season has kickstarted and volatility has returned after causing market turmoil last month. Although earnings results are better than expected in the very early period of this cycle, other macro economic and political factors have flared up market fluctuations.

At this stage, it will be prudent to invest in low-beta (beta value less than 1 but greater than zero) stocks with a favorable Zacks Rank as these will be less volatile than the broader market. On Oct 21, seven such companies are set to beat on earnings results and witness an uptrend in their stock prices in near future.

Consequently, investment in low-beats stocks with a favorable Zacks Rank and positive Earnings ESP will be a sound strategy to enhance one's portfolio.    

Sources of Volatility in October

First, on Oct 14, U.S. Treasury Secretary Steven Mnuchin expressed concerns that the second round of coronavirus-aid package is unlikely to come before the U.S. presidential election scheduled on Nov 3. The U.S. Congress has failed to reach a solution regarding the size and scope of a fresh fiscal stimulus despite negotiating for more than two months.

Second, it seems a remote possibility that a vaccine or a proper line of treatment for COVID-19 will appear this year. This week the FDA has paused late-stage clinical trials of two drugs for the potential treatment of conronavirus on safety concerns. Meanwhile, several states and regions in the United States and major Eurozone countries have recently witnessed another spike in COVID-19 infections as these economies are trying to return to normalcy.

Third, the U.S. presidential election is less than three weeks away. Historically, stock markets have remained volatile during the month before the election. Market participants generally choose to hold cash instead of investing in risky assets like equities while assessing the economic and financial consequences of the election result.

Solid Q3 Earnings Results So Far

The third-quarter earnings season has started on a strong note though overall earnings are likely to remain negative this quarter. As of Oct 14, 36 S&P 500 companies have reported results. Total earnings of these companies are down 14.1% from the same period last year on 1% lower revenues, with 88.9% beating EPS estimates and 75% surpassing revenue estimates.

Meanwhile, for the quarter as a whole, total S&P 500 earnings are expected to decline 19.3% on 2.5% lower revenues. This is an improvement over an earnings decline of 22% year over year on 2.9% lower revenues, as projected before the starting of the reporting cycle.

Notably, overall projections for third-quarter earnings have gradually improved since July, on the reopening of a large part of the U.S. economy. Importantly, the pace of improvement has started accelerating as companies have come up with better-than-expected results. (Read More: Good Start to Q3 Earnings Season)

Our Top Picks

We have narrowed down our search to seven low-beta stocks that are slated to release earnings results on Oct 21. Each of these stocks carries either a Zacks Rank #1 (Strong Buy) or 2 (Buy) and has a positive Earnings ESP. You can see the complete list of today’s Zacks #1 Rank stocks here.

Our research shows that for stocks with the combination of a Zacks Rank #3 (Hold) or better and a positive Earnings ESP, the chance of an earnings beat is as high as 70%. These stocks are anticipated to appreciate after earnings releases. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Abbott Laboratories discovers, develops, manufactures and sells a diversified line of health care products worldwide. This Zacks Rank # 2 company has an Earnings ESP of +5.30%. Abbott Laboratories has an expected earnings growth rate of 1.9% for the current year.

The Zacks Consensus Estimate for current-year earnings has improved 0.9% over the last 7 days. It has a trailing four-quarter earnings surprise of 12.7%, on average. The company has a beta of 0.92 and is set to release earnings results on Oct 21, before the opening bell.

NextEra Energy generates, transmits, distributes, and sells electric power to retail and wholesale customers in North America through its  wind, solar, nuclear and natural gas-fired facilities. The company has an Earnings ESP of +0.92%.

NextEra Energy has an expected earnings growth rate of 9.4% for the current year. The Zacks Consensus Estimate for the current year has improved 0.3% over the last 30 days. It has a trailing four-quarter earnings surprise of 2.7%, on average. The Zacks Rank #2 company has a beta of 0.20 and is set to release earnings results on Oct 21, before the opening bell.

Silgan Holdings manufactures and sells rigid packaging for consumer goods products in North America, Europe, and internationally. It operates through three segments: Metal Containers, Closures, and Plastic Containers. This Zacks Rank # 2 company has an Earnings ESP of +3.81%.

Silgan Holdings has an expected earnings growth rate of 31.9% for the current year. The Zacks Consensus Estimate for the current year has improved 0.4% over the last 30 days. It has a trailing four-quarter earnings surprise of 12.8%, on average. The company has a beta of 0.72 and is set to release earnings results on Oct 21, before the opening bell.

UniFirst Corp. provides workplace uniforms and protective workwear clothing in the United States, Europe, and Canada. It operates through U.S. Rental and Cleaning, Canadian Rental and Cleaning, Manufacturing, Specialty Garments Rental and Cleaning, and First Aid segments. This Zacks Rank # 2 company has an Earnings ESP of +12.07% for the fourth-quarter fiscal 2020 (ended August 2020).

The Zacks Consensus Estimate for UniFirst for the current year has improved 0.4% over the last 30 days. It has a trailing four-quarter earnings surprise of 13.3%, on average. The company has a beta of 0.89 and is set to release earnings results on Oct 21, before the opening bell.

Landstar System provides integrated transportation management solutions in the United States, Canada, Mexico, and internationally. It operates through two segments, Transportation Logistics, and Insurance. This Zacks Rank # 1 company has an Earnings ESP of +3.58%.

The Zacks Consensus Estimate for Landstar System for the current year has improved 8.9% over the last 30 days. It has a trailing four-quarter earnings surprise of 3.2%, on average. The company has a beta of 0.65 and is set to release earnings results on Oct 21, after the closing bell.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                          

 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Published in